Developing microenvironment-based prognostic biomarkers for early breast cancer [ 7/1/2021 - 6/30/2024 ]

Research Grant

Brief description Approximately 20% of breast cancer patients are now diagnosed with ductal carcinoma in situ (DCIS), an early stage where tumour cells are confined within the ducts of the breast and pose no threat to life. Once cells spread beyond the duct into surrounding breast tissue, risk of spread increases dramatically. This project aims to use a unique set of patient samples to identify markers that predict DCIS patients that are most at risk of spread, to personalise therapy to and reduce over-treatment.

Funding Amount $132,743

Funding Scheme Postgraduate Scholarships

Chief Investigator Dr Christina Kozul

Notes Clinical Medicine and Science Research Scholarship